Bradykinin receptor antagonists with neurokinin receptor blocking activity
US5610140A · kind A · utility
13Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 1994 |
| Grant date | Mar 11, 1997 |
| Priority date | — |
| Expiry date | Aug 1, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/816
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a heterodimeric compound possessing bradykinin and neurokinin receptor antagonist activities useful in the treatment of asthma and other inflammatory diseases especially those involving the airway or pulmonary system. The present invention is also useful in the treatment of pain and inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.